股 票 代 码 ： 0 0 0 5 1 8 股 票 简 称 ： * ST 四 环 公 告 编 号 ： 临 - 2 0 2 6 - 0 1 号 江苏四环生物股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：股票交易已被实施财务类退市风险警示后的首个会计年 度、预计净利润为负值 | | | | | | 单位：万元 | | --- | --- | --- | --- | --- | --- | | 项 目 | 本报告期 | | | | 上年同期 | | 利润总额 | -4,200 | | ～ | -3,200 | -11,373.31 | | | 比上年同期增长 | 63.07% | ～ | 71.86% | | | 归属于上市公司股 | -4,000 | | ～ | -3,000 | -10,999.37 | | 东的净利润 | 比上年同期增长 | 63.63% | ～ | 72.73% | | | 扣除 ...

Group 1 - The biopharmaceutical sector increased by 0.19% on January 21, with Nearshore Protein leading the gains [1] - The Shanghai Composite Index closed at 4116.94, up 0.08%, while the Shenzhen Component Index closed at 14255.12, up 0.7% [1] - Key stocks in the biopharmaceutical sector showed significant price increases, with Nearshore Protein rising by 6.37% to a closing price of 48.76 [1] Group 2 - The biopharmaceutical sector experienced a net inflow of 77.04 million yuan from institutional investors, while retail investors saw a net outflow of 284 million yuan [2] - Major stocks like Watson Bio and Ganli Pharmaceutical attracted significant institutional investment, with net inflows of 64.45 million yuan and 55.25 million yuan, respectively [3] - Retail investors showed a negative trend in several stocks, with Watson Bio and Ganli Pharmaceutical experiencing net outflows of 33.30 million yuan and 39.14 million yuan, respectively [3]

Market Overview - As of January 19, the Shanghai Composite Index rose by 0.29% to close at 4114.0001 points, while the Shenzhen Component Index increased by 0.09% to close at 14294.053 points [1] Top Gainers in Hunan Stocks - Changlan Technology opened at 20.800 and closed at 22.990, achieving a daily increase of 7.83%, with a highest price of 23.350 and a lowest price of 20.580, trading volume reached 310,056 lots [2] - Changgao Electric New opened at 9.630 and closed at 10.220, marking a daily rise of 7.58%, with a highest price of 10.300 and a lowest price of 9.590, trading volume was 907,740 lots [2] - Jinbei Electric opened at 13.550 and closed at 14.340, reflecting a daily increase of 5.75%, with a highest price of 14.340 and a lowest price of 13.550, trading volume was 530,320 lots [2] - Boyun New Materials opened at 11.580 and closed at 12.380, showing a daily rise of 5.72%, with a highest price of 12.640 and a lowest price of 11.510, trading volume reached 683,175 lots [2] - *ST Biological opened at 8.360 and closed at 8.930, achieving a daily increase of 5.06%, with a highest price of 8.930 and a lowest price of 8.360, trading volume was 39,799 lots [2] Top Losers in Hunan Stocks - Hengli Retreat opened at 0.160 and closed at 0.150, experiencing a daily drop of 11.76%, with a highest price of 0.170 and a lowest price of 0.150, trading volume was 611,606 lots [3] - Kaimete Gas opened at 23.120 and closed at 22.590, reflecting a daily decline of 2.67%, with a highest price of 23.290 and a lowest price of 22.500, trading volume reached 566,571 lots [3] - ST Jiajia opened at 6.700 and closed at 6.540, marking a daily decrease of 2.39%, with a highest price of 6.760 and a lowest price of 6.540, trading volume was 52,505 lots [3] - Tuowei Information opened at 33.940 and closed at 33.770, showing a daily drop of 1.29%, with a highest price of 34.400 and a lowest price of 33.630, trading volume reached 53,496 lots [3] - Aoshikang opened at 41.650 and closed at 41.130, experiencing a daily decline of 1.25%, with a highest price of 41.650 and a lowest price of 40.850, trading volume was 32,232 lots [3]

Market Overview - As of December 30, the Shanghai Composite Index closed at 3965.1159 points, unchanged at 0% [1] - The Shenzhen Component Index rose by 0.49%, closing at 13604.067 points [1] Top Gainers in Hunan Stocks - *ST Zhanggu opened at 7.570 and closed at 7.570, with a gain of 4.99% [2] - *ST Gaosi opened at 8.230 and closed at 8.550, with a gain of 4.14% [2] - Mengjie Co., Ltd. opened at 3.910 and closed at 4.030, with a gain of 2.81% [2] - Keli'er opened at 13.390 and closed at 13.610, with a gain of 2.48% [2] - Changlan Technology opened at 18.310 and closed at 18.890, with a gain of 1.94% [2] Top Losers in Hunan Stocks - Hengli Tui opened at 0.160 and closed at 0.150, with a loss of 11.76% [3] - Dianguang Media opened at 11.580 and closed at 10.350, with a loss of 10.00% [3] - Boyun New Materials opened at 12.050 and closed at 11.720, with a loss of 4.95% [3] - Hunan Silver opened at 6.960 and closed at 6.990, with a loss of 3.98% [3] - *ST Biology opened at 9.190 and closed at 8.830, with a loss of 3.29% [3]

Group 1 - The core viewpoint of the article is that *ST SiHuan (000518.SZ) has a year-round seedling sales business, with spring and autumn being peak sales seasons [1] Group 2 - The company engages in seedling sales throughout the year, indicating a stable business model [1] - Spring and autumn are identified as the peak seasons for sales, suggesting potential for increased revenue during these periods [1]

Group 1 - The biopharmaceutical sector increased by 0.18% on December 25, with Jindike leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] - Key stocks in the biopharmaceutical sector showed various performance, with Jindike (688670) rising by 4.66% to a closing price of 22.45 [1] Group 2 - The biopharmaceutical sector experienced a net outflow of 307 million yuan from institutional investors, while retail investors saw a net inflow of 359 million yuan [2] - Notable declines included Te Bao Biological (688278), which fell by 3.14% to a closing price of 80.90 [2] - The trading volume and turnover for various stocks in the sector varied significantly, with Wan Ze Co. (000534) achieving a turnover of 488 million yuan [1][2] Group 3 - Jindike (688670) had a net inflow of 25.23 million yuan from institutional investors, while retail investors had a net outflow of 23.95 million yuan [3] - Other stocks like Zhi Xiang Jin Tai (688443) and Shen Zhou Cell (688520) also showed mixed net inflows and outflows from different investor categories [3] - The overall trend indicates a divergence in investor sentiment, with institutional investors pulling back while retail investors increased their positions [2][3]

Group 1 - The Shanghai Composite Index closed at 3958.00 points, above the annual line, with a change of 0.43% [1] - The total trading volume of A-shares reached 1552.045 billion yuan [1] - A total of 131 A-shares have surpassed the annual line, with notable stocks including Xusheng Group, Chongqing Port, and *ST Zhisheng showing significant deviation rates of 8.27%, 8.15%, and 4.95% respectively [1] Group 2 - Stocks with the highest deviation rates from the annual line include: - Xusheng Group (10.01% increase, 8.74% turnover rate, latest price 15.38 yuan, deviation rate 8.27%) - Chongqing Port (10.02% increase, 2.26% turnover rate, latest price 5.82 yuan, deviation rate 8.15%) - *ST Zhisheng (4.98% increase, 3.86% turnover rate, latest price 11.60 yuan, deviation rate 4.95%) [1] - Other stocks with smaller deviation rates that have just crossed the annual line include Hu塑股份, Hu鑫股份, and Heng申新材 [1]

Core Viewpoint - The market experienced mixed performance with the ChiNext index closing down 0.44%, while the influenza and organic silicon sectors surged, indicating a divergence in market sentiment driven by specific sectoral developments [1][4]. Group 1: Influenza Sector - The influenza sector saw a significant uptick, with flu-like cases in northern provinces rising to 7.0%, markedly higher than the same period in previous years [4]. - Sales of antiviral drugs, such as Oseltamivir, surged by 237% over the past week, indicating strong demand driven by rising flu cases [4]. - Jindike has completed the production season with 1.56 million doses of its quadrivalent flu vaccine approved for release, and is ramping up production capacity to 30 million doses [4]. Group 2: Organic Silicon Sector - The organic silicon sector experienced a boost following Dow Chemical's announcement of a 10%-20% price increase on major products starting December 10, which acted as a catalyst for domestic stocks [4]. - Companies like Hongbai New Materials and Chenguang New Materials saw their stocks hit the daily limit, while Dongyue Silicon Material rose over 10% [4]. - Smart money has already positioned itself in this sector, with Chenguang New Materials seeing a net inflow of 85.14 million yuan over the past ten trading days [4]. Group 3: Underperforming Sectors - The Hainan sector faced significant declines, with companies like Jingliang Holdings and Hainan Haiyao dropping nearly 7%, highlighting the lack of performance support for regional themes [4]. - The film and content industry also struggled, with Huanrui Century hitting the daily limit down and Shanghai Film falling nearly 7%, reflecting uncertainty in the content sector [4]. Group 4: Market Sentiment and Strategy - The overall trading volume decreased by 93.5 billion yuan compared to the previous day, indicating a cautious market sentiment and a tendency for rapid sector rotation [4]. - Investment strategies suggest focusing on the influenza sector for low-entry opportunities and the organic silicon sector for potential gains, while avoiding sectors lacking performance, policy support, or growth potential [5].

Core Insights - The biopharmaceutical sector experienced a decline of 0.98% on November 18, with He Yuan Bio leading the drop [1] - The Shanghai Composite Index closed at 3939.81, down 0.81%, while the Shenzhen Component Index closed at 13080.49, down 0.92% [1] Stock Performance Summary - Notable gainers included: - Aopu Mai (688293) with a closing price of 58.80, up 3.38% on a trading volume of 15,900 shares and a transaction value of 93.39 million [1] - Jin Hu Ke (688670) at 26.80, up 2.88% with a volume of 116,300 shares and a transaction value of 319 million [1] - Te Bao Bio (688278) at 77.08, up 1.22% with a volume of 10,800 shares and a transaction value of 82.57 million [1] - Notable decliners included: - Bu Yuan Bio (688765) at 79.95, down 3.89% with a volume of 56,800 shares and a transaction value of 458 million [2] - San Sheng Guo Jian (688336) at 67.60, down 3.87% with a volume of 68,100 shares and a transaction value of 469 million [2] - Wo Wu Bio (300357) at 31.77, down 3.23% with a volume of 77,900 shares and a transaction value of 250 million [2] Capital Flow Analysis - The biopharmaceutical sector saw a net outflow of 981 million from institutional investors, while retail investors contributed a net inflow of 819 million [2] - Key stocks with significant capital flow included: - Hua Lan Vaccine (301207) with a net inflow of 48.51 million from institutional investors [3] - Rong Chang Bio (688331) with a net inflow of 23.62 million from institutional investors [3] - Jin Ke (688670) with a net inflow of 5.53 million from institutional investors [3]

Market Overview - The biopharmaceutical sector experienced a slight decline of 0.08% on November 11, with He Yuan Bio leading the drop [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - Notable gainers included: - Jin Ke (688670) with a closing price of 24.97, up 19.99% on a trading volume of 134,300 shares and a transaction value of 310 million [1] - Kanghua Bio (300841) closed at 83.21, up 6.04% with a trading volume of 57,100 shares [1] - Watson Bio (300142) closed at 12.82, up 2.64% with a trading volume of 942,000 shares [1] - Significant losers included: - Bu Yuan Bio (688765) closed at 86.00, down 8.02% with a trading volume of 107,600 shares [2] - Ao Pu Mai (688293) closed at 59.18, down 3.65% with a trading volume of 17,900 shares [2] - Rongchang Bio (688331) closed at 86.00, down 2.55% with a trading volume of 45,900 shares [2] Capital Flow - The biopharmaceutical sector saw a net outflow of 671 million from institutional investors, while retail investors contributed a net inflow of 335 million [2] - The capital flow for key stocks showed: - Jin Ke had a net inflow of 48.11 million from institutional investors, but a net outflow of 24.49 million from speculative funds [3] - Zhifei Bio (300122) experienced a net inflow of 15.25 million from institutional investors, with a net outflow of 23.20 million from retail investors [3] - Kanghua Bio had a net inflow of 14.35 million from institutional investors, but a net outflow of 23.26 million from speculative funds [3]